Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

CORT
Corcept Therapeutics Inc.
stock NASDAQ

At Close
Jun 13, 2025 3:59:44 PM EDT
70.12USD-1.489%(-1.06)1,008,688
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jun 13, 2025 9:26:30 AM EDT
71.20USD+0.021%(+0.02)100
After-hours
Jun 13, 2025 4:01:30 PM EDT
70.06USD+0.014%(+0.01)2,207
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
7.43B
CEO
Joseph Belanoff
Headquarters
Menlo Park, California, USA
Industry
Biotechnology
Next Earnings
Jul 28, 2025 (42d)
Related
NVSBMYJNJLLYPFEESPRMYLCBIOMNKDXLV
CORT Stats
Avg. Vol. 10 Day
1,737,436
Avg. Vol. 30 Day
1,387,745
Employees
136
Market Cap
7,428,430,955
Shares Out.
106,044,696
On/Off Exchange
57%/43%
6 Month Beta
1.16
1 Year Beta
1.11
2 Year Beta
1.12
3 Year Beta
0.94
52 Week Low
28.04
52 Week High
117.33
SMA50
71.76
SMA200
58.46
1 Week
-0.74%
1 Month
-6.70%
3 Month
+21.03%
6 Month
+26.38%
1 Year
+145.02%
2 Year
+202.85%
5 Year
+349.04%
Profile
leading the field in the discovery of drugs that modulate the effects of cortisol the adverse effects of excess cortisol have been corcept's focus since the company's inception. abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol. in addition to our work with mifepristone, we have developed over 300 proprietary molecules, advancing the most promising of these to the clinic to see if they can mitigate the effects of excess cortisol and the serious, sometimes life-threatening conditions that may result. all of these compounds competitively block the glucocorticoid receptor (gr), but not the progesterone receptor. scientific literature suggests that competitive gr antagonism may have a role in treating many conditions, including post-traumatic stress disorder, mild cognitive impairment, alzheimer's disease, alcoholis

CORT Stock Summary

Corcept Therapeutics Inc. (NASDAQ:CORT) stock price today is $70.12, and today's volume is 1,008,688. CORT is down -1.489% today. The 30 day average volume is 1,387,745. CORT market cap is 7.43B with 106,044,696 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC